TY  - GEN
AU  - Sircar,Geetabali
AU  - Goswami,Rudra Prosad
AU  - Sircar,Dipankar
AU  - Ghosh,Alakendu
AU  - Ghosh,Parasar
TI  - Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
SN  - 1462-0332
PY  - 2019///0812
KW  - Adult
KW  - Antirheumatic Agents
KW  - therapeutic use
KW  - Cyclophosphamide
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Lung
KW  - pathology
KW  - Lung Diseases, Interstitial
KW  - drug therapy
KW  - Male
KW  - Rituximab
KW  - Scleroderma, Diffuse
KW  - complications
KW  - Severity of Illness Index
KW  - Skin
KW  - Treatment Outcome
KW  - Vital Capacity
KW  - drug effects
KW  - Walk Test
N1  - Publication Type: Equivalence Trial; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1093/rheumatology/key213
ER  -